GLP1R and psoriasis: In humans, the GLP-1 pathways act as a modulator of a specific subset of T-cells, known as invariant natural killer T (iNKT) cells, and this activity might be responsible for the improvements of some immune-mediated disorders (such as psoriasis and suppurative hidradenitis) observed in obese patients treated with GLP-1 RAs (51–54).